Given its better valuation, we believe Walgreens stock (NYSE: WBA) is a better pick than its peer CVS Health stock (NYSE: CVS). WBA stock trades at 0.1x revenues, versus 0.2x for CVS, given the latter's superior revenue growth, profitability, and financial position.
Walgreens Boots Alliance (WBA) reachead $15.92 at the closing of the latest trading day, reflecting a -1.85% change compared to its last close.
Retail pharmacy chain Walgreens (NASDAQ: WBA ) is seeing shares pop sharply higher on Thursday following a big announcement. Billed as a “summer of savings,” the company will lower prices on 1,300 items.
Walgreens has faced headwinds and cut its dividend by nearly 50% earlier this year. The company's recent earnings showed some positive signs, but headwinds persist, which could lead to an additional dividend cut by the end of the year. The dividend coverage is a concern as operating cash flow and free cash flow were negative in the first half of the year.
Shares of Walgreens Boots Alliance (WBA) fell over 3% Wednesday after the pharmacy retailer announced plans to join the growing list of retailers cutting prices to win back customers who have changed their shopping habits to deal with inflation.
Walgreens is joining a growing number of companies that are cutting prices on a number of goods to lure in shoppers and boost sales in the midst of inflation.
Walgreens Boots Alliance Inc. said Wednesday it was continuing to lower prices as part of its “Summer of Savings” promotional campaign, this time on more than 1,300 products — but that announcement didn't stop the drugstore chain's stock from falling toward a 27-year low.
Walgreens has been hurt by industry reimbursement pressures. The company also made a poor acquisition with its large investment in VillageMD.
Walgreens Boots Alliance (WBA) concluded the recent trading session at $16.03, signifying a +0.5% move from its prior day's close.
Investors are optimistic about Walgreens Boots (WBA), led by strategic alliances and new product launches.
Walgreens stock (NYSE: WBA) currently trades at $17 per share, about 70% below the level seen in April 2021, and it appears undervalued. WBA stock was trading at around $38 in early June 2022, just before the Fed started increasing rates, and is now 56% below that level, compared to 41% gains for the S&P 500 over this period.
Companies' attempted clampdowns on home working has led to a rise in staff nipping in and out of offices in order to simply gain credit, research suggests. One in three people in the UK able to flexibly work admit to so-called “coffee badging”, according to Telegraph-cited research by hybrid working company Owl Labs.